Vancouver, British Columbia – January 12, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology... View Article
Vancouver, British Columbia – December 31, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a... View Article
December 16, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a... View Article
Vancouver, British Columbia – December 2, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA”... View Article
Messenger RNA Diagnostic/Treatment Paradigm Vancouver, British Columbia – November 9, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE:... View Article
Vancouver, British Columbia – November 4, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA”... View Article
Psilocybin Fragile X Syndrome Treatment Vancouver, British Columbia – November 2, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q)... View Article
Vancouver, British Columbia – October 26, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA”... View Article
Partnership will Create Patented Products for the Treatment of Neuroinflammatory Disorders October 19, 2021 – Nova Mentis Life Science... View Article
Vancouver, British Columbia – September 14, 2021 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA”... View Article